The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes.
about
Effect of exercise on the level of immunoglobulin a in salivaAsialoglycoprotein receptor deficiency in mice lacking the major receptor subunit. Its obligate requirement for the stable expression of oligomeric receptor.A 'clicked' tetrameric hydroxamic acid glycopeptidomimetic antagonizes sugar-lectin interactions on the cellular levelExploring Site-Specific N-Glycosylation of HEK293 and Plant-Produced Human IgA Isotypes.Enhancement of recombinant human EPO production and glycosylation in serum-free suspension culture of CHO cells through expression and supplementation of 30Kc19.A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy.Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages.Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy.IgA receptors in health and disease.Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI bindingA comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targetingUpstream and downstream processing of recombinant IgA.Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity.Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles.Immunoglobulin Glycosylation Effects in Allergy and Immunity.Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibody.IgA EGFR antibodies mediate tumour killing in vivo.Enhancement of recombinant human EPO production and sialylation in chinese hamster ovary cells through Bombyx mori 30Kc19 gene expression.Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines.Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy.Stabilization of cellular mitochondrial enzyme complex and sialyltransferase activity through supplementation of 30Kc19 protein.Association of liver cirrhosis related IgA nephropathy with portal hypertension.Kidneys in chronic liver diseases.Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo.Improving protein pharmacokinetics by genetic fusion to simple amino acid sequences.T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy.Radiolabelled polymeric IgA: from biodistribution to a new molecular imaging tool in colorectal cancer lung metastases.Carbohydrate-Polypeptide Contacts in the Antibody Receptor CD16A Identified through Solution NMR Spectroscopy.Glycosylation Profiling of α/β T Cell Receptor Constant Domains Expressed in Mammalian Cells.Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia
P2860
Q27007183-8D528C21-E779-4C56-9590-DD0EF5481780Q30661651-F632DC2A-DE5F-46F7-BC73-20BAE2B95FDEQ33827411-862A8937-B2CB-4C5F-8090-3E9E81988D4FQ33891585-61107D2C-C7B8-42FA-957B-726687620A69Q34309532-0C398CB9-F31D-438A-BBF4-E6F7CAC34A11Q34318898-169CB7F6-F40F-449A-BC4B-96F98B2BD18EQ36082694-D2773AF7-E92D-41FF-AD67-82F70C4C546DQ36127055-6C1AB704-0C5E-40E1-AE2E-8DCC41CEFF18Q36369552-B9FEB58B-868D-4BD5-B4B7-03FA7A5E611EQ36546463-B60AF386-5EEC-4AE8-A4AE-757C9A367898Q36967139-338D055D-B11F-4F45-B931-74EA35B6F487Q37138274-72EDB597-582E-49C4-B1D8-C893F8EB2A95Q37138332-41FD7058-0671-4F23-BC6C-DB2615AC86D6Q38254478-4B8C0507-6EB5-45D4-8B46-8C56E702AAF7Q38497438-45868011-FFC5-4F75-8196-677C32E3847EQ38618893-5F951543-08EB-45B6-8647-C9CC3B36CF58Q38994739-F480FE6A-5185-4DE5-B54F-577F0AC57788Q39027573-46479328-8F4A-4CA7-A993-FDD4AD235B42Q39114924-19A8F879-1D8B-4633-8092-74DCB6E0412EQ39588845-37EDF0CE-F466-4CAD-A5A6-F95E4DD3F617Q39709073-8AA16433-113E-4856-B496-B723A0296C19Q41704272-E7708670-7A6F-4E94-B568-CA3E43061685Q42001813-BC7F0070-1979-4CF1-ACCC-A39A852C4165Q42036740-8F115E7E-B459-4909-B60D-72B84E6F8E0FQ43209206-EA8C842F-212C-4FCA-BEA1-D8166B9ED985Q43691927-5ECD7594-C54F-4A19-9F5E-DE3DB530200CQ44652104-19B5CF39-B77A-44DF-AFEC-0EA7672A2F77Q46476267-320A85C8-4458-4EFC-9BC1-39D1B894E519Q47114808-A7EDA112-62F6-4E08-BB89-9EA069F212F1Q48278565-ABCA80C6-E128-4DE5-B3A0-F64CE0C0F3B8Q51113846-C2E08ADC-195A-4AD9-BA9C-766DB73B1E13Q57217591-14965611-E8FD-4026-84D3-13F6AB459B56
P2860
The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The N-glycans determine the di ...... ulin (Ig)A1 and IgA2 isotypes.
@ast
The N-glycans determine the di ...... ulin (Ig)A1 and IgA2 isotypes.
@en
type
label
The N-glycans determine the di ...... ulin (Ig)A1 and IgA2 isotypes.
@ast
The N-glycans determine the di ...... ulin (Ig)A1 and IgA2 isotypes.
@en
prefLabel
The N-glycans determine the di ...... ulin (Ig)A1 and IgA2 isotypes.
@ast
The N-glycans determine the di ...... ulin (Ig)A1 and IgA2 isotypes.
@en
P2093
P2860
P356
P1476
The N-glycans determine the di ...... ulin (Ig)A1 and IgA2 isotypes.
@en
P2093
K R Chintalacharuvu
S L Morrison
P2860
P304
P356
10.1084/JEM.191.12.2171
P407
P577
2000-06-01T00:00:00Z